About Stefan Steinsen My name is Stefan Steinsen and I was born in Iceland 45 years ago. I ve been married for 23 years and we have four children, three girls and one boy.
Here are her own words on LDN. IT IS NOURE BUT IT IS THE BEST. AND CLOSEST THING WE HAVE TO ONE. A PERSON CAN TAKE. LDN BY ITSELF OR WITH ANOTHER TREATMENT BUT ONE.
Contact the doctor right away if any signs of suicidal thoughts or actions occur. Discuss any questions with the patient s doctor. Naltrexone is not approved for use in children. Talk with the doctor.
Closely monitor patients for respiratory depression when initiating therapy with EMBEDA and following dose increases. Accidental Ingestion. Accidental ingestion of even one dose of EMBEDA, especially by children, can result in a respiratory depression and death due to an overdose of morphine.
I couldnt understand why, maybe it was because their brains already had all the endorphins they needed, and any outside opiates would result in overkill. Either way, I could care less, I had found my niche, and thats all that mattered.
What should I tell my health care provider before I take this medicine? They need to know if you have any of these conditions: if you have used drugs or alcohol within 7 to 10 days kidney disease liver disease, including hepatitis an unusual or.
Maybe I should just thank Reckitt for watching out for Americas children, and end this post here. But I have to admit that I am not feeling that warm and fuzzy about Reckitts announcement.We need to be clear about that. Packaging changes may help reduce the risk, but the switch to film doesnt solve the problem. WARNING : KEEP MEDICATION, INCLUDING SUBOXONE TABLETS AND SUBOXONE FILM OUT OF REACH OF CHILDREN. This would increase the cost of the generic tablets and make it harder for the generic maker to compete in the market. Funny, they never did that when they were making the tablets!
If you want to keep generic competition out of the market Reckitt, how about lowering the cost of the medication? You will allow more people access to Suboxone treatment, and make it less likely that another company will make a generic version of Suboxone to.But if the pill bottle was full of Skittles and not Suboxone, we wouldnt be worrying about children overdosing. And we wouldnt need to worry about individual, child-resistant wrapping of Suboxone film.
I fully recognize the huge benefits many people have experienced from Suboxone treatment. I see it every day. Thats why I would like to see generic Suboxone available. With 1.2 billion US dollars in Suboxone sales in 2011 alone, I think Reckitt has more than.And even if altruism is part of the motive here, I cant help but believe that profit motives delayed the decision to pull Suboxone tablets from the market until after Suboxone film was FDA approved, manufactured, marketed and selling well.
Reckitt is trying to say that the issue is the packaging, not the medication. And it seems like they may be implying that since Suboxone film is better packaged, it solves the risk to children.Reckitt wants to look like the responsible adult in the room by volunteering to discontinue access to Suboxone tablets. But they have a financial incentive to make that move beyond the altruistic desire to protect children.
Children can die from an accidental overdose if they swallow the medication. Unlike tablets, film or strips are individually wrapped, and data from the US Poison Control Centers shows that this has resulted in safety benefits for children.One line in their press release bothered me. It reads, The pediatric exposure safety issue is not related to the active ingredients found in both Suboxone Tablets and Suboxone Film. Really?
Suboxone is a treatment for opioid dependence. Reckitt says that the change will likely happen within the next six months. Issue One: Child Safety The company says that the move is motivated by a desire to help keep children from gaining access to the medication.Suboxone in tablet form lost patent protection in 2009, but Suboxone in film form is still protected by patent. If Suboxone film becomes the standard, Reckitt doesnt have to worry about competition from a generic version of the medication coming into the market.
Issue Two: Access To Suboxone Treatment. If Reckitt is in an altruistic mood, how about supporting access to generic versions of Suboxone so that more people can afford the treatment? Instead, Reckitt is working to make it harder for competitors to enter the market.The statement seems a little less than accurate and more than a little self-serving. Damn skippy the risk to children has to do with what is in the bottle or the wrapper!